Detalles de la búsqueda
1.
Risk stratification of ischaemic patients with implantable cardioverter defibrillators by C-reactive protein and a multi-markers strategy: results of the CAMI-GUIDE study.
Eur Heart J
; 33(11): 1344-50, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22285581
2.
Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report.
J Med Case Rep
; 11(1): 224, 2017 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28806993
3.
Concomitant myasthenia gravis, myositis, myocarditis and polyneuropathy, induced by immune-checkpoint inhibitors: A life-threatening continuum of neuromuscular and cardiac toxicity.
eNeurologicalSci
; 14: 4-5, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30533536
4.
Compliance to MADIT and MUSTT criteria for implantable cardioverter defibrillator therapy in the pre-SCD-Heft and MADIT II era. Data from a multicenter Italian study.
Int J Cardiol
; 144(2): 268-9, 2010 Oct 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-19232761
Resultados
1 -
4
de 4
1
Próxima >
>>